8-KMaterial AgreementsExhibits & Filings

ABBOTT LABORATORIES 8-K Report, Material Agreement (Feb 21, 2006)

Filed February 21, 2006For Securities:ABT

Summary

This 8-K filing from Abbott Laboratories, dated February 21, 2006, reports a material amendment to its Non-Employee Directors' Fee Plan. Effective April 28, 2006, the plan will provide enhanced monthly compensation for the Audit Committee Chairman and its members, recognizing the increasing demands of their roles. Specifically, the Audit Committee Chairman will receive an additional $1,500 per month, and other Audit Committee members will receive an additional $500 per month. This adjustment aims to appropriately compensate directors for their oversight responsibilities, particularly in the context of evolving corporate governance and compliance requirements. Investors should view this as a move to ensure continued strong governance and attract experienced individuals to these critical board positions.

Key Highlights

  • 1Abbott Laboratories amended its Non-Employee Directors' Fee Plan, effective April 28, 2006.
  • 2The amendment increases monthly compensation for Audit Committee members.
  • 3The Audit Committee Chairman will receive an additional $1,500 per month.
  • 4Other members of the Audit Committee will receive an additional $500 per month.
  • 5The changes reflect the increasing demands on the Audit Committee's oversight responsibilities.
  • 6The amended and restated Non-Employee Directors' Fee Plan is filed as an exhibit.

Frequently Asked Questions

The primary purpose of this filing is to announce an amendment to Abbott Laboratories' Non-Employee Directors' Fee Plan, which enhances the compensation for members of the Audit Committee.

The amended fee structure will be effective as of the 2006 Annual Meeting, which is scheduled for April 28, 2006.

The filing states that the increase is in recognition of the increasing demands on the audit committee chairman and members, suggesting a response to evolving corporate governance and compliance responsibilities.

The financial impact is relatively minor given the total operational costs of a large corporation like Abbott. The increase is on director fees, specifically for a committee, rather than broad employee compensation. The exact dollar amount would depend on the number of Audit Committee members and their tenure, but it's primarily an investment in governance oversight.